PedAM
Pediatric Disease Annotations & Medicines
| Disease | b-cell lymphomas |
| Phenotype | C0024299|lymphoma |
| Sentences | 13 |
| PubMedID- 22423238 | Mucosa-associated lymphoid tissue (malt) lymphoma comprises 7–8% of all b-cell lymphomas and at least 50% of primary gastric lymphomas [1]. |
| PubMedID- 26045870 | Mantle cell lymphoma is one of the b-cell lymphomas. |
| PubMedID- 25983828 | Most primary spinal lymphomas are comprised of diffuse large b-cell lymphomas with a minority being follicular lymphoma, precursor b-lymphoblastic lymphoma, ki-lymphoma, diffuse lymphoblastic lymphoma, small lymphocytic lymphoma or t-cell lymphoma5). |
| PubMedID- 22315486 | Background: mantle cell lymphoma accounts for 6% of all b-cell lymphomas and is generally incurable. |
| PubMedID- 24238277 | Although an advanced clinical study has been reported on a t-cell lymphoma, the potential of mv ovt against b-cell lymphomas remains to be clarified. |
| PubMedID- 22560334 | Mantle cell lymphoma (mcl) is one of the most difficult b-cell lymphomas to be treated. |
| PubMedID- 23901714 | Among nhls, epstein-barr virus was found to be positive in 50% cases with diffuse large b-cell lymphoma and 11.8% of low grade b-cell lymphomas. |
| PubMedID- 20086245 | Mantle cell lymphoma (mcl) is one of the most aggressive b-cell lymphomas. |
| PubMedID- 22511234 | Mantle cell lymphoma (mcl) is one of the most aggressive b-cell lymphomas with a median patient survival of only 5-7 years. |
| PubMedID- 20346013 | In some haematological malignancies, like burkitt lymphoma (bl) and subsets of diffuse large b-cell lymphomas, elevated myc levels are a direct consequence of genomic aberrations involving the myc locus. |
| PubMedID- 22120970 | Burkitt lymphoma and a subset of diffuse large b-cell lymphomas are characterized by chromosomal alterations affecting the myc oncogene on 8q24. |
| PubMedID- 22977788 | Burkitt lymphoma is one of the b-cell lymphomas. |
| PubMedID- 23776377 | There is not only a progression from mbl to cll, but cll is also able to undergo further clinicopathologic transformation to become an aggressive lymphoma with a predominance of diffuse large b-cell lymphomas. |
Page: 1